MiRNA Overexpression Induces Cardiomyocyte Proliferation in Vivo

Overview

Journal Mol Ther

Publisher Cell Press

Specialties Molecular Biology
Pharmacology

Date 2013 Mar 2

PMID 23449102

Citations 6

Authors

Andrew H Baker

Eva Van Rooij

Affiliations

Soon will be listed here.

Citing Articles

MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways.

Wu X, Chen Y, Zhu Y, Cui F J Cancer. 2022; 13(6):1895-1904.

PMID: 35399721 PMC: 8990416. DOI: 10.7150/jca.60269.

Engineered macrophage membrane-enveloped nanomedicine for ameliorating myocardial infarction in a mouse model.

Xue Y, Zeng G, Cheng J, Hu J, Zhang M, Li Y Bioeng Transl Med. 2021; 6(2):e10197.

PMID: 34027086 PMC: 8126824. DOI: 10.1002/btm2.10197.

MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.

Dong Y, Zou J, Su S, Huang H, Deng Y, Wang B Mol Med Rep. 2015; 12(1):1016-22.

PMID: 25816091 PMC: 4438929. DOI: 10.3892/mmr.2015.3516.

Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.

Parikh A, Wu J, Blanton R, Tzanakakis E Tissue Eng Part B Rev. 2015; 21(4):377-92.

PMID: 25813860 PMC: 4533091. DOI: 10.1089/ten.TEB.2014.0662.

Targeting of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces Glutathione Biosynthesis and Promotes TGF-β-Dependent Fibrogenesis.

Espinosa-Diez C, Fierro-Fernandez M, Sanchez-Gomez F, Rodriguez-Pascual F, Alique M, Ruiz-Ortega M Antioxid Redox Signal. 2014; 23(14):1092-105.

PMID: 25353619 PMC: 4657521. DOI: 10.1089/ars.2014.6025.

References

Van Rooij E, Olson E . MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012; 11(11):860-72. PMC: 6813819. DOI: 10.1038/nrd3864. View

Hullinger T, Montgomery R, Seto A, Dickinson B, Semus H, Lynch J . Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res. 2011; 110(1):71-81. PMC: 3354618. DOI: 10.1161/CIRCRESAHA.111.244442. View

Song X, Li Q, Lin L, Wang X, Li D, Wang G . MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol. 2010; 225(2):437-43. DOI: 10.1002/jcp.22217. View

Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View

Shatseva T, Lee D, Deng Z, Yang B . MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci. 2011; 124(Pt 16):2826-36. DOI: 10.1242/jcs.077529. View

Porrello E, Mahmoud A, Simpson E, Hill J, Richardson J, Olson E . Transient regenerative potential of the neonatal mouse heart. Science. 2011; 331(6020):1078-80. PMC: 3099478. DOI: 10.1126/science.1200708. View

Small E, Olson E . Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011; 469(7330):336-42. PMC: 3073349. DOI: 10.1038/nature09783. View

Lee M, Prasain N, Chae H, Kim Y, Mantel C, Yoder M . Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells. 2012; 31(4):666-81. PMC: 3904370. DOI: 10.1002/stem.1302. View

Willems E, Spiering S, Davidovics H, Lanier M, Xia Z, Dawson M . Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res. 2011; 109(4):360-4. PMC: 3327303. DOI: 10.1161/CIRCRESAHA.111.249540. View

10.

Jopling C, Sleep E, Raya M, Marti M, Raya A, Izpisua Belmonte J . Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature. 2010; 464(7288):606-9. PMC: 2846535. DOI: 10.1038/nature08899. View

11.

Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J . Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009; 104(7):879-86. PMC: 3332328. DOI: 10.1161/CIRCRESAHA.108.193102. View

12.

Mohsin S, Siddiqi S, Collins B, Sussman M . Empowering adult stem cells for myocardial regeneration. Circ Res. 2011; 109(12):1415-28. PMC: 3266718. DOI: 10.1161/CIRCRESAHA.111.243071. View

13.

Van Rooij E, Purcell A, Levin A . Developing microRNA therapeutics. Circ Res. 2012; 110(3):496-507. DOI: 10.1161/CIRCRESAHA.111.247916. View

14.

Dimmeler S, Zeiher A, Schneider M . Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005; 115(3):572-83. PMC: 1052009. DOI: 10.1172/JCI24283. View

15.

Fornari F, Milazzo M, Chieco P, Negrini M, Calin G, Grazi G . MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010; 70(12):5184-93. DOI: 10.1158/0008-5472.CAN-10-0145. View

16.

Kikuchi K, Holdway J, Werdich A, Anderson R, Fang Y, Egnaczyk G . Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010; 464(7288):601-5. PMC: 3040215. DOI: 10.1038/nature08804. View

17.

Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M . Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J. 2010; 32(10):1287-97. DOI: 10.1093/eurheartj/ehq369. View

18.

Porrello E, Mahmoud A, Simpson E, Johnson B, Grinsfelder D, Canseco D . Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci U S A. 2012; 110(1):187-92. PMC: 3538265. DOI: 10.1073/pnas.1208863110. View

19.

Porrello E, Johnson B, Aurora A, Simpson E, Nam Y, Matkovich S . MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res. 2011; 109(6):670-9. PMC: 3167208. DOI: 10.1161/CIRCRESAHA.111.248880. View

20.

Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A . MicroRNAs impair MET-mediated invasive growth. Cancer Res. 2008; 68(24):10128-36. DOI: 10.1158/0008-5472.CAN-08-2148. View